Substituting latanoprost (Xalatan) for isopropyl unoprostone (Rescula) in monotherapy and combination therapy

Acta Ophthalmol Scand. 2000 Oct;78(5):604-5. doi: 10.1034/j.1600-0420.2000.078005604.x.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Dinoprost / analogs & derivatives
  • Dinoprost / therapeutic use*
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Glaucoma, Open-Angle / drug therapy*
  • Humans
  • Intraocular Pressure / drug effects*
  • Latanoprost
  • Male
  • Middle Aged
  • Ocular Hypertension / drug therapy
  • Ophthalmic Solutions
  • Prostaglandins F, Synthetic / therapeutic use*
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Ophthalmic Solutions
  • Prostaglandins F, Synthetic
  • isopropyl unoprostone
  • Latanoprost
  • Dinoprost